|
Dr.
Ahmad Al Ghazawi
President and CEO, Triumpharma
Dr. Al Ghazawi is currently President and CEO of Triumpharma a
product development and clinical evaluation center, in Amman,
Jordan, with a strong emphasis on designing novel and new drug
delivery systems. Dr. Al Ghazawi has over 14 years of
experience in the pharmaceutical sector. He worked with Merck and
GlaxoSmithKline for five years as a scientist later becoming the
Technical and Development manager responsible for directing,
designing, and development of a new and existing Merck drug delivery
system (DDS).
As well as being involved in the designing, patenting, and
commercialization of the new technologies developed in-house.
He has been and still is involved as an inventor or co-inventor of
several patents/patent applications in different pharmaceutical
field. Dr. Al Ghazawi is a member of the American Association
of Pharmaceutical Scientists (AAPS), USA; the Controlled Release
Society Inc., USA; the Royal Pharmaceutical Society of Great
Britain-Academy of Pharmaceutical Sciences, the Aerosol Society, UK.
Dr. Al Ghazawi received his PhD from the School of Pharmacy,
University of London, UK and his B.Pharm, for the Jordan University
of Science and Technology.
Lorna
Brazell
Partner, Bird & Bird
Lorna
specializes in the protection of intellectual property in all its
forms. Her experience spans drafting and negotiating commercial
contracts for the creation, transfer or licensing of intellectual
property at all stages in its lifecycle, advising on regulatory
strategies for the pharmaceutical industry and the enforcement of
rights through litigation in the High Court and Patents County Court
across a range of industries.
With a background in the physical sciences, she has developed
particular expertise in patent litigation, including the management
of parallel litigation in several jurisdictions. Lorna has also
worked on a variety of issues relating to e-commerce, including the
establishment of certification authorities, the legal status of
encryption technology and the use of digital signatures.
Lorna publishes widely in books and journals on a range of topics
relating to her areas of interest. Lorna authored a chapter on
recent European case law on pharmaceutical pricing strategies and
the approach the European Commission is taking to the current issues
in "The Pharmaceutical Pricing Compendium" (Urch, 2003). She is the
author of Electronic Signature Law and Regulation (Sweet & Maxwell,
2004) and co-author with Trevor Cook of The Copyright Directive: UK
Implementation (Jordans, 2004).
Hanan J.
Sboul
Secretary General, Jordanian Association of Pharmaceutical
Manufacturers (JAPM)
Ms. Hanan J. Sboul is currently the Secretary General of the
Jordanian Association of Pharmaceutical Manufacturers in Jordan.
Prior to that, Ms. Sboul has had extensive experience in the
pharmaceuticals field working as a Pharmacy Programs Director on
Commercial Markets Strategies, a USAID funded project, and as Drug
administration officer with Jordan Food and Drug. Ms. Hanan J.
Sboul is a member of the Sera and Vaccines Registration Committee.
Ms. Hanan J. Sboul received her B.Sc in Pharmacy and MBA in
Marketing form the University of Jordan in Amman.
Donald Grant Kelly
Senior Consultant, International Intellectual Property Institute
(IIPI)
Chief Executive Officer, Intellectual Asset Management Associates (IAMA)
Intellectual property consultant and registered patent practitioner
Don Kelly is widely known for his educational and entertaining
lectures on such topics as invention, American innovation,
intellectual property protection and commercialization. Recently, he
was named by the executive board of the Rothschild Patent Model
Museum and Invention Center as Executive Director of the newly
chartered New York State institution. Following graduation from VA
Tech, with a BS in Mechanical Engineering, Kelly served for more
than three decades with the US Patent and Trademark Office (USPTO),
where he directed divisions of patent examiners and served on the
senior executive staff of a number of USPTO Commissioners. His
public service career included postings as Science Advisor to a US
Congressman, and with the Office of the United States Trade
Representative (USTR) as the Washington-Geneva Coordinator to the
Tokyo Round of GATT Negotiations. At the National Technical
Information Service (NTIS) Don Kelly established and directed the
Center for Utilization of Federal Technology (CUFT) to facilitate
transfer and commercialization of federally funded inventions under
the Stevenson-Wydler Act.
Just prior to forming IAMA, Kelly served for two years as CEO of the
prestigious Academy of Applied Science, and as Adjunct Professor at
Franklin Pierce Law Center. He is a visiting lecturer at MIT Sloan
School and Fordham University Graduate School of Business, and a
member of the Licensing Executives Society (LES) professional
development faculty. Kelly also teaches technology resource
management for the Asia Pacific Legal Institute's Intellectual
Property Training Program. He also serves as Vice Chair of the
Intellectual Property Owners Assn. Committee on Small Business and
Independent Inventors, and as corporate director for PatentCafe,
Inc.
Maher
S. Matalka
Director of Economics and Commerce Bureau (EBC), Embassy of Jordan,
Washington DC
Maher S. Matalka was appointed on May 1, 2003 as Director of
Economic and Commerce Bureau (EBC) in Washington DC. The newly
established EBC aims to foster and strengthen Jordan-US economic
relations and bilateral trade ties, by facilitating and encouraging
Jordanian exports to the US as well as US investments in Jordan.
Prior to his assignment in Washington, he headed the Jordan
Association of Pharmaceutical Manufacturers (JAPM) as Secretary
General. He advised the pharmaceutical industry on key
domestic and international strategic and development related issues
as well as healthcare matters. In addition he represented the
industry’s interests by serving on various committees such as World
Bank on pharmaceutical reforms, WTO membership, Jordan-US Free Trade
Agreement, Intellectual Property (IP) and Trade Policy related
issues.
Mr. Matalka participated in various regional and international
forums on intellectual property and presented several papers on the
challenges and opportunities facing the pharmaceutical industry in
the developing counties. Mr. Matalka contributed significantly
to the development of the pharmaceutical industry infrastructure in
Jordan, leading the industry into unconventional markets, ultimately
resulting in the successful registration and sales of Jordanian
generics into such markets as the European Union. He has also
participated in developing “Jordan Vision 2020”, an ambitious
initiative that aims to achieve a clear private sector driven
economic strategy to guide Jordan into the 21st century.
Mr. Matalka holds a Masters in Intellectual Property (MIP) from
Franklin Pierce Law Center in Concord New Hampshire, and a B. Sc.in
Pharmaceuticals from Stanford University.
Michael P. Ryan, Ph.D.
Senior Consultant, International Intellectual Property Institute
(IIPI)
Assistant Professor, McDonough School of Business, Georgetown
University
Professor Michael P. Ryan began assisting the Jordanian economic
reform effort in 1998 when he was asked by USAID to draft new patent
and plant variety protection laws in support of its accession to the
World Trade Organization. In the years since he has lectured
frequently in Jordan regarding intellectual property and technology
policy and management, e.g., at the invitation of the Higher Council
for Science and Technology and the Royal Scientific Society at its
technology entrepreneurship conference and at the invitation of the
Young Entrepreneurs Association at its annual conference. In
cooperation with USAID-AMIR, the US Patent and Trademark Office, and
the International Intellectual Property Institute (Washington, DC)
he established and has lectured at the annual King Abdullah II
Intellectual Property Week conference. The IP Week conference
involves the software, info tech, pharmaceutical, and bio-medical
business communities, university researchers, government
policymakers and public administrators, and judges who settle
intellectual property-based commercial disputes. During 2003-4
Professor Ryan, funded by USAID-AMIR and the Washington-based
Pharmaceutical Research and Manufacturers of America, is with a
colleague assessing Jordan's pharmaceutical and bio-medical
institutional infrastructure (law, regulation and public
administration, business strategy, university research) in
cooperation with the Jordan Pharmaceutical Manufacturers Association
and Jordan Intellectual Property Association. The report will be
released in August 2004 at a conference under the patronage of the
His Majesty King Abdullah II. In 2003 he lectured members of the
Ministry of Economics, Palestinian Authority, in Ramallah, West
Bank, under auspices of USAID. He, USAID, and the local authorities
have designed an intellectual property policy and economic reform
program that will be carried out when security and diplomatic
circumstances permit.
Professor Ryan, an associate research professor of policy and ethics
at Georgetown University's McDonough School of Business, and a
senior consultant to the International Intellectual Property
Institute, is advising and lecturing Thailand's business,
government, university, and judicial communities in order to assist
with their national bio-medical strategy. He co-authored a report
for the university system of South Africa concerning the
commercialization of technology and the establishment of university
technology transfer offices. He has also lectured business and
policy communities in Argentina, Brazil, Bulgaria, Chile, China,
Croatia, the Dominican Republic, Japan, Malaysia, Peru, the
Philippines, and Singapore. His Intellectual Property Rules! Trade
Secrets, Patents, Copyrights, and Trademarks in the World Economy
will be published in fall 2004; his co-authored (with Paul Almeida)
Knowledge Strategy: Technology, Intellectual Property, and
Organization in the World Economy will be published in 2005 as will
his Knowledge Ethics: Intellectual Property and Social
Responsibilities in the World Economy. He is the author of Knowledge
Diplomacy: Global Competition and the Politics of Intellectual
Property (1998) and Playing by the Rules: American Trade Power and
Diplomacy in the Pacific (1995). He holds a PhD in political science
with concentrations in international political economy,
organization, and law from the University of Michigan, holds a
master's degree in philosophy from Ohio State University, and
previously served on the faculty of the Michigan Business School.
Farouk
Salama
Regional Managing Director, Middle East & Iraq, Merck
Mr. Farouk Salama is the Regional Managing Director for the Middle
East and Iraq at Merck & Co. Inc since1993. Mr. Salama has a
vast experience with Merck, a global research driven pharmaceutical
products company, where he began in 1976. He is responsible
for the management and marketing of the broad range of human and
animal health products in the region.
Prior to Merck, Mr. Salama was an Assistant Researcher at the
National Research Institute in Egypt and a lecturer at the Faculty
of Veterinary Medicine, in Egypt. Mr. Salama holds a Bachelors
degree in Animal Health Science and Surgery as well as a
Postgraduate degree in Veterinary Hematology.
|
